ARS Pharmaceuticals Files 8-K on Shareholder Vote Matters

Ticker: SPRY · Form: 8-K · Filed: Jun 26, 2025 · CIK: 1671858

Ars Pharmaceuticals, Inc. 8-K Filing Summary
FieldDetail
CompanyArs Pharmaceuticals, Inc. (SPRY)
Form Type8-K
Filed DateJun 26, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-meeting

TL;DR

ARS Pharma held a shareholder vote on 6/25, details to follow.

AI Summary

ARS Pharmaceuticals, Inc. filed an 8-K on June 26, 2025, reporting on a submission of matters to a vote of security holders that occurred on June 25, 2025. The company, formerly known as Silverback Therapeutics, Inc., is incorporated in Delaware and headquartered in San Diego, California.

Why It Matters

This filing indicates that ARS Pharmaceuticals held a meeting or vote involving its security holders, which could pertain to significant corporate decisions or governance changes.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of a shareholder vote, not indicating immediate financial distress or significant operational changes.

Key Players & Entities

  • ARS Pharmaceuticals, Inc. (company) — Registrant
  • Silverback Therapeutics, Inc. (company) — Former company name
  • June 25, 2025 (date) — Date of earliest event reported
  • June 26, 2025 (date) — Date of report
  • Delaware (jurisdiction) — State of incorporation
  • San Diego, California (location) — Principal executive offices location

FAQ

What specific matters were submitted to a vote of ARS Pharmaceuticals' security holders on June 25, 2025?

The filing states that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in this initial 8-K filing.

When was ARS Pharmaceuticals, Inc. formerly known as Silverback Therapeutics, Inc.?

The company's name changed from Silverback Therapeutics, Inc. on April 12, 2016.

Where are ARS Pharmaceuticals, Inc.'s principal executive offices located?

The principal executive offices are located at 11682 El Camino Real, Suite 120, San Diego, California, 92130.

What is the SEC file number for ARS Pharmaceuticals, Inc.?

The SEC file number for ARS Pharmaceuticals, Inc. is 001-39756.

What is the standard industrial classification for ARS Pharmaceuticals, Inc.?

The standard industrial classification for ARS Pharmaceuticals, Inc. is Pharmaceutical Preparations [2834].

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 26, 2025 regarding ARS Pharmaceuticals, Inc. (SPRY).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.